Primary outcome:Pain symptoms, assessed by VAS, including:Pelvic pain: pain localized to the pelvic regionDysmenorrhea: pain during menstruationDyspareunia: pain during intercourseOverall pain: a general category of pain not specific to any particular location or type, including pain described as “worst pain,” “endometriosis-associated pain,” or simply “pain.”Secondary outcomes:Oxidative stress biomarkers, including: MDA, TAC, SOD, and LOOHClinical pregnancy rateMeasurement timepoints: All outcomes were assessed at baseline (pre-intervention) and at the end of the intervention. This evidence concerns the gene SOD1 and endometriosis.